Fei Zhen-Tao, Xia Lu, Yang Yang, Ye Dan, Liu Hua-Rui, Liu Ping, Huang Wei, Li Feng, Liu Xu-Hui
Shanghai Public Health Clinical Center, Fudan University, Shanghai, China.
School of Medicine, Fudan University, Shanghai, China.
Open Forum Infect Dis. 2024 Nov 19;11(12):ofae686. doi: 10.1093/ofid/ofae686. eCollection 2024 Dec.
Tuberculous meningitis (TBM) can lead to ophthalmic nerve palsy (ONP), a severe neurological complication. This study aims to evaluates the incidence and risk factors for ONP in TBM patients.
This retrospective study included 250 TBM patients from the Shanghai Public Health Clinical Center (2013-2022). Clinical and imaging data were analyzed, with logistic regression identifying risk factors for ONP.
ONP occurred in 6.8% (17/250) of TBM patients. Those with ONP had higher intracranial pressure (ICP) (257.69 ± 68.12 mmH2O vs 191.65 ± 91.58 mmH2O; = 0.012), cerebrospinal fluid protein levels, and a higher prevalence of tuberculomas (29.4% vs 10.7%; = 0.039). Logistic regression identified pre-treatment ICP, CD4 percentage, and tuberculomas as significant risk factors. Linezolid use was a protective factor for ONP recovery.
Six point eight percent (17/250) of patients with TBM developed ONP as a complication. ICP, CD4 counts, and tuberculomas are key predictors. Linezolid shows potential as a therapeutic agent for improving outcomes in TBM patients with neurological complications, warranting further study.
结核性脑膜炎(TBM)可导致严重的神经并发症——视神经麻痹(ONP)。本研究旨在评估TBM患者中ONP的发生率及危险因素。
这项回顾性研究纳入了上海公共卫生临床中心2013年至2022年期间的250例TBM患者。对临床和影像学数据进行分析,采用逻辑回归确定ONP的危险因素。
250例TBM患者中有6.8%(17/250)发生ONP。发生ONP的患者颅内压(ICP)更高(257.69±68.12mmH₂O vs 191.65±91.58mmH₂O;P = 0.012),脑脊液蛋白水平更高,结核瘤患病率更高(29.4% vs 10.7%;P = 0.039)。逻辑回归确定治疗前ICP、CD4百分比和结核瘤为显著危险因素。使用利奈唑胺是ONP恢复的保护因素。
6.8%(17/250)的TBM患者发生ONP并发症。ICP、CD4计数和结核瘤是关键预测因素。利奈唑胺显示出作为改善伴有神经并发症的TBM患者预后的治疗药物的潜力,值得进一步研究。